Two Sigma Advisers’s Madrigal Pharmaceuticals MDGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-900
| Closed | -$261K | – | 2681 |
|
|
2022
Q4 | $261K | Buy |
+900
| New | +$261K | ﹤0.01% | 2112 |
|
|
2022
Q2 | – | Sell |
-2,982
| Closed | -$293K | – | 2797 |
|
|
2022
Q1 | $293K | Sell |
2,982
-2,200
| -42% | -$216K | ﹤0.01% | 2227 |
|
|
2021
Q4 | $439K | Sell |
5,182
-30,458
| -85% | -$2.58M | ﹤0.01% | 1973 |
|
|
2021
Q3 | $2.84M | Sell |
35,640
-49,300
| -58% | -$3.93M | 0.01% | 1064 |
|
|
2021
Q2 | $8.27M | Sell |
84,940
-30,900
| -27% | -$3.01M | 0.02% | 644 |
|
|
2021
Q1 | $13.6M | Buy |
115,840
+76,300
| +193% | +$8.92M | 0.04% | 466 |
|
|
2020
Q4 | $4.4M | Buy |
39,540
+21,000
| +113% | +$2.33M | 0.01% | 877 |
|
|
2020
Q3 | $2.2M | Buy |
18,540
+6,342
| +52% | +$753K | 0.01% | 1113 |
|
|
2020
Q2 | $1.38M | Buy |
+12,198
| New | +$1.38M | ﹤0.01% | 1413 |
|
|
2019
Q1 | – | Sell |
-19,698
| Closed | -$2.22M | – | 2387 |
|
|
2018
Q4 | $2.22M | Buy |
19,698
+11,789
| +149% | +$1.33M | 0.01% | 1130 |
|
|
2018
Q3 | $1.69M | Buy |
7,909
+700
| +10% | +$150K | ﹤0.01% | 1308 |
|
|
2018
Q2 | $2.02M | Buy |
7,209
+400
| +6% | +$112K | 0.01% | 1287 |
|
|
2018
Q1 | $795K | Buy |
+6,809
| New | +$795K | ﹤0.01% | 1643 |
|
|
2016
Q2 | – | Sell |
-27,472
| Closed | -$7K | – | 2136 |
|
|
2016
Q1 | $7K | Sell |
27,472
-209,323
| -88% | -$53.3K | ﹤0.01% | 2014 |
|
|
2015
Q4 | $83K | Buy |
+236,795
| New | +$83K | ﹤0.01% | 1787 |
|